Atlantic American Corporation has received a significant update regarding its trading status on the Nasdaq Global Market. On November 11, 2026, the company was notified by the Nasdaq Hearings Panel that it has granted the company's request to extend the stay of the trading suspension of its common stock. This decision allows Atlantic American to appeal a previous determination from the Nasdaq Listing Qualifications Department that aimed to delist the company's shares.

This matter is crucial not only for Atlantic American but also for the broader life insurance industry, which is currently navigating various regulatory challenges. The company is scheduled for a hearing on December 1, 2026, where it will present its case to the Panel.

Background

Atlantic American Corporation, incorporated in Georgia, is primarily engaged in the life insurance sector, classified under SIC 6311. The company trades on the Nasdaq under the ticker symbol AAME. Recent filings indicate that the company has faced challenges in meeting its reporting obligations, which led to the recent delisting determination.

What the Filing Says

The recent SEC filing states, "the Panel has granted the Company’s request to extend the stay of the trading suspension of the Company’s common stock from the Nasdaq Global Market pending the outcome of the Company’s hearing before the Panel scheduled for December 1, 2026." This indicates a temporary reprieve for Atlantic American as it prepares for the upcoming hearing.

Impact

This development may affect various stakeholders, including shareholders and potential investors, who are watching closely to see if Atlantic American can successfully appeal the delisting decision. The outcome of the hearing could also impact the company’s operations and market perception.

What's Next

The next significant event will be the hearing scheduled for December 1, 2026, where Atlantic American will present its case to the Nasdaq Hearings Panel. The filing does not specify what happens next beyond this hearing.